Cargando…
Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma
Pathological stage is the most important prognostic factor in patients with lung cancer, and is defined according to the tumor node metastasis classification system. The present study aimed to investigate the clinicopathological significance of lymphatic invasion in 103 patients who underwent surgic...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364981/ https://www.ncbi.nlm.nih.gov/pubmed/28260029 http://dx.doi.org/10.3892/mmr.2017.6256 |
_version_ | 1782517434218971136 |
---|---|
author | Masuda, Ryota Kijima, Hiroshi Nito, Madoka Wada, Atsushi Matsuzaki, Tomohiko Ikoma, Yoichiro Nakazato, Kenei Masuda, Daisuke Tanaka, Makiko Kobayashi, Hiroyuki Inokuchi, Sadaki Iwazaki, Masayuki |
author_facet | Masuda, Ryota Kijima, Hiroshi Nito, Madoka Wada, Atsushi Matsuzaki, Tomohiko Ikoma, Yoichiro Nakazato, Kenei Masuda, Daisuke Tanaka, Makiko Kobayashi, Hiroyuki Inokuchi, Sadaki Iwazaki, Masayuki |
author_sort | Masuda, Ryota |
collection | PubMed |
description | Pathological stage is the most important prognostic factor in patients with lung cancer, and is defined according to the tumor node metastasis classification system. The present study aimed to investigate the clinicopathological significance of lymphatic invasion in 103 patients who underwent surgical resection of lung squamous cell carcinoma (SqCC). The patients were divided into two groups, according to the degree of lymphatic invasion: Those with no or mild lymphatic invasion (ly0-1) and those with moderate or severe lymphatic invasion (ly2-3). Ly2-3 was associated with tumor size (P=0.028), lymph node metastasis (P<0.001), venous invasion (P=0.001) and histological differentiation (P=0.047). Statistical analysis using the Kaplan-Meier method and the log-rank test indicated that overall survival was significantly reduced in patients with ly2-3 compared with those with ly0-1 (P<0.001). Multivariate analysis identified ly2-3 as an independent predictor of mortality (hazard ratio, 2.580; 95% confidence interval, 1.376–4.839). In conclusion, moderate or severe lymphatic invasion (ly2-3) indicated a high malignant potential and may be considered an independent predictor of poor prognosis in patients with SqCC of the lung. |
format | Online Article Text |
id | pubmed-5364981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-53649812017-05-15 Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma Masuda, Ryota Kijima, Hiroshi Nito, Madoka Wada, Atsushi Matsuzaki, Tomohiko Ikoma, Yoichiro Nakazato, Kenei Masuda, Daisuke Tanaka, Makiko Kobayashi, Hiroyuki Inokuchi, Sadaki Iwazaki, Masayuki Mol Med Rep Articles Pathological stage is the most important prognostic factor in patients with lung cancer, and is defined according to the tumor node metastasis classification system. The present study aimed to investigate the clinicopathological significance of lymphatic invasion in 103 patients who underwent surgical resection of lung squamous cell carcinoma (SqCC). The patients were divided into two groups, according to the degree of lymphatic invasion: Those with no or mild lymphatic invasion (ly0-1) and those with moderate or severe lymphatic invasion (ly2-3). Ly2-3 was associated with tumor size (P=0.028), lymph node metastasis (P<0.001), venous invasion (P=0.001) and histological differentiation (P=0.047). Statistical analysis using the Kaplan-Meier method and the log-rank test indicated that overall survival was significantly reduced in patients with ly2-3 compared with those with ly0-1 (P<0.001). Multivariate analysis identified ly2-3 as an independent predictor of mortality (hazard ratio, 2.580; 95% confidence interval, 1.376–4.839). In conclusion, moderate or severe lymphatic invasion (ly2-3) indicated a high malignant potential and may be considered an independent predictor of poor prognosis in patients with SqCC of the lung. D.A. Spandidos 2017-04 2017-02-28 /pmc/articles/PMC5364981/ /pubmed/28260029 http://dx.doi.org/10.3892/mmr.2017.6256 Text en Copyright: © Masuda et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Masuda, Ryota Kijima, Hiroshi Nito, Madoka Wada, Atsushi Matsuzaki, Tomohiko Ikoma, Yoichiro Nakazato, Kenei Masuda, Daisuke Tanaka, Makiko Kobayashi, Hiroyuki Inokuchi, Sadaki Iwazaki, Masayuki Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title | Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title_full | Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title_fullStr | Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title_full_unstemmed | Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title_short | Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
title_sort | lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364981/ https://www.ncbi.nlm.nih.gov/pubmed/28260029 http://dx.doi.org/10.3892/mmr.2017.6256 |
work_keys_str_mv | AT masudaryota lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT kijimahiroshi lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT nitomadoka lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT wadaatsushi lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT matsuzakitomohiko lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT ikomayoichiro lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT nakazatokenei lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT masudadaisuke lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT tanakamakiko lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT kobayashihiroyuki lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT inokuchisadaki lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma AT iwazakimasayuki lymphaticinvasionisasignificantindicatorofpoorpatientprognosisinlungsquamouscellcarcinoma |